Genetic polymorphism of the serotonin transporter gene, SLC6A4 rs16965628, is associated with obsessive compulsive disorder

Genetic Testing and Molecular Biomarkers

Volumn 19, Issue 5, 2015, Pages 228-234

  Cengiz, Mujgan ^a   Okutan, Saide Nur ^b   Bayoglu, Burcu ^a   Sakalli Kani, Ayse ^a   Bayar, Reha ^a   Kocabasoglu, Nese ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COMP PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADOLESCENT; AGED; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84929332648     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2014.0319     Document Type: Article

References (38)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed. American Psychiatric Press, Washington, DC.
2. Bloch MH, Landeros-Weisenberger A, Sen S, et al. (2008) Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am J Med Genet B Neuropsychiatr Genet 147B:850-858.
3. Chabane N, Millet B, Delorme R, et al. (2004) Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett 363:154-156.
4. Chen J, Lipska BK, Halim N, et al. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
5. Delorme R, Betancur C, Callebert J, et al. (2005) Platelet serotonergic markers as endo phenotypes for obsessive-compulsive disorder. Neuropsychopharmacology 30:1539-1547.
6. Delorme R, Chabane N, Callebert J, et al. (2004) Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder. J Clin Psychopharmacol 24:18-23.
7. Denys D, Van Nieuwerburgh F, Deforce D, et al. (2006) Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16:446-450.
8. Erdal ME, Tot S, Yazici K, et al. (2003) Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 18:41-45.
9. First MB, Spitzer RL, Gibbon M, et al. (1995) Structured Clinical Interview for DSM-IV Axis Disorders, Patient Edition (SCID-P). Version 2. Psychiatric Institute, Biometric Research, New York.
10. Funke B, Malhotra AK, Finn CT, et al. (2005) COMT genetic variation confers risk for psychotic and affective disorders: A case control study. Behav Brain Funct 1:19.
11. Goodman WK, Price LH, Rasmussen SA, et al. (1989) The Yale-brown obsessive compulsive scale. I. Development, use, andreliability. Arch Gen Psychiatry 46:1006-1011.
12. Grisham JR, Fullana MA, Mataix-Cols D, et al. (2011) Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. Psychol Med 41:2495-2506.
13. Iervolino AC, Rijsdijk FV, Cherkas L, et al. (2011) A multivariate twin study of obsessive-compulsive symptom dimensions. Arch Gen Psychiatry 68:637-644.
14. Kaiser R, Tremblay PB, Schmider J, et al. (2001) Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psychiatry 6:179-185.
15. Katerberg H, Cath DC, Denys DA, et al. (2010) The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 153B:167-176.
16. Lachman HM, Popolis DF, Saito T, et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of functional polymorphism and its potential application to neuropsichiatric disorders. Pharmacogenetics 6:243-250.
17. Lee KY, Joo EJ, Ahn YM, et al. (2005) Catechol-O-methyltransferase gene polymorphism and treatment response to clozapine in refractory schizophrenia. Korean J Psychopharmacol 16.
18. Lei X, Chen C, He Q, et al. (2012) Sex determines which section of the SLC6A4 gene is linked to obsessive-compulsive symptoms in normal Chinese college students. J Psychiatr Res 46:1153-1160.
19. Lesch KP, Bengel D, Heils A, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
20. Lindholm Carlström E, Saetre P, Rosengren A, et al. (2012) Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia. Behav Brain Funct 8:24.
21. Liu S, Liu Y, Wang H, et al. (2011) Association of catechol-Omethyltransferase (COMT) gene-287A/G polymorphism with susceptibility to obsessive-compulsive disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 156B:393-400.
22. Mataix-Cols D, Boman M, Monzani B, et al. (2013) Populationbased, multigenerational family clustering study of obsessivecompulsive disorder. JAMA Psychiatry 70:709-717.
23. McDougle CJ, Epperson CN, Price LH, et al. (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive-compulsive disorder. Mol Psychiatry 3:270-273.
24. Meira-Lima I, Shavitt RG, Miguita K, et al. (2004) Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 3:75-79.
25. Murphy DL, Fox MA, Timpano KR, et al. (2008) How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55:932-960.
26. Niehaus DJ, Kinnear CJ, Corfield VA, et al. (2001) Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord 65:61-65.
27. Opstad TB, Pettersen AA, Arnesen H, Seljeflot I. (2011) Circulating levels of IL-18 are significantly influenced by the IL-18 + 183A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol 10:110.
28. Pizarro M, Fontenelle LF, Paravidino DC, et al. (2014) An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder. Expert Opin Pharmacother 15:1391-1401.
29. Prasansuklab A, Poovorawan Y, Tencomnao T (2011) Modulation of human serotonin transporter expression by 5-HTTLPR in colon cells. Int J Mol Sci 12:6619-6634.
30. Ramamoorthy S, Bauman AL, Moore KR, et al. (1993) Antidepressant-andcocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90:2542-2546.
31. Rasmussen SA, Eisen JL (1990) Epidemiology of obsessive compulsive disorder. Clin Psychiatry 51:10-13.
32. Samuels J, Wang Y, Riddle MA, et al. (2011) Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 156B:472-477.
33. Schechter LE, Ring RH, Beyer CE, et al. (2005) Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx 2:590-611.
34. Taylor S (2013) Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies. Mol Psychiatry 18:799-805.
35. Tibrewal P, Kumar HB, Shubha GN, et al. (2010) Association of serotonin transporter gene polymorphisms with obsessivecompulsive disorder (OCD) in a south Indian population. Indian J Med Res 132:690-695.
36. Visser HA, Van Oppen P, Van Megen HJ, et al. (2014) Obsessive-compulsive disorder; chronic versus non-chronic symptoms. J Affect Disord 152-154:169-174.
37. Wendland JR, Moya PR, Kruse MR, et al. (2008) A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet 17:717-723.
38. Zai G, Brandl EJ, Müller DJ, et al. (2014) Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians. Pharmacogenomics 15:1147-1157.